Segment Information

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Segment Information

Segment Information

During the three months ended June 30, 2023, the Company renamed its Industrial segment as "Technologies."

Beginning January 1, 2023, the Company began measuring segment performance to include the impact of expenses identified as non-operating. Previously, these expenses would have been included with Corporate and other. Segment income (loss) from operations for the three and six months ended June 30, 2022 has been adjusted for comparability.

The following table summarizes select operating results for each reportable segment (in millions).

	Three Months Ended June 30,		Three Months Ended June 30,		Six Months Ended June 30,		Six Months Ended June 30,
	2023		2022		2023		2022
Revenues
Medical	$	68.0	$	66.8	$	134.4	$	126.9
Technologies	129.2		109.0		244.9		212.1
Consolidated Revenues	$	197.2	$	175.8	$	379.3	$	339.0
Segment (Loss) Income from Operations
Medical	$	(3.1)	$	(2.2)	$	(2.4)	$	(8.9)
Technologies	12.8		(46.5)		18.3		(49.0)
Total Segment (Loss) Income from Operations	9.7		(48.7)		15.9		(57.9)
Corporate and other	(20.3)		(25.9)		(40.1)		(50.3)
Consolidated Loss from Operations	$	(10.6)	$	(74.6)	$	(24.2)	$	(108.2)

The Company’s assets by reportable segment were not included, as this information is not reviewed by, nor otherwise provided to, the chief operating decision maker to make operating decisions or allocate resources.

The following details revenues by geographic region. Revenues generated from external customers are attributed to geographic regions through sales from site locations (i.e., point of origin) (in millions).

	Revenues
	Three Months Ended June 30,		Three Months Ended June 30,		Six Months Ended June 30,		Six Months Ended June 30,
	2023		2022		2023		2022
North America
Medical	$	62.2	$	61.7	$	122.9	$	117.3
Technologies	64.1		49.8		119.3		92.0
Total North America	126.3		111.5		242.2		209.3
Europe
Medical	5.8		5.1		11.5		9.6
Technologies	63.4		57.9		116.5		111.1
Total Europe	69.2		63.0		128.0		120.7
Asia Pacific
Medical	—		—		—		—
Technologies	1.7		1.3		9.1		9.0
Total Asia Pacific	1.7		1.3		9.1		9.0
Total revenues	$	197.2	$	175.8	$	379.3	$	339.0

The following details revenues by timing of recognition (in millions):

	Revenues
	Three Months Ended June 30,		Three Months Ended June 30,		Six Months Ended June 30,		Six Months Ended June 30,
	2023		2022		2023		2022
Point in time	$	124.8	$	117.2	$	243.1	$	234.2
Over time	72.4		58.6		136.2		104.8
Total revenues	$	197.2	$	175.8	$	379.3	$	339.0

The following details revenues by product category (in millions):

	Revenues
	Three Months Ended June 30,		Three Months Ended June 30,		Six Months Ended June 30,		Six Months Ended June 30,
	2023		2022		2023		2022
Medical segment:
Medical	$	68.0	$	66.8	$	134.4	$	126.9
Technologies segment:
Reactor Safety and Control Systems	51.1		34.7		93.2		65.5
Radiological Search, Measurement, and Analysis Systems	78.1		74.3		151.7		146.6
Total revenues	$	197.2	$	175.8	$	379.3	$	339.0